Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 460,145 | 550,176 | 190,428 | 243,274 | 170,884 |
| Marketable Securities | 707,719 | 620,458 | 609,582 | 496,291 | 612,871 |
| Receivables | N/A | N/A | 268 | N/A | 1,696 |
| TOTAL | $1,202,247 | $1,203,930 | $830,137 | $759,934 | $806,381 |
| Non-Current Assets | |||||
| PPE Net | 22,913 | 23,769 | 24,727 | 25,128 | 23,698 |
| Investments And Advances | 33,286 | 94,838 | 217,306 | 370,938 | 389,980 |
| Other Non-Current Assets | 17,097 | 17,213 | 17,501 | 18,123 | 21,989 |
| TOTAL | $73,296 | $135,820 | $259,534 | $414,189 | $435,667 |
| Total Assets | $1,275,543 | $1,339,750 | $1,089,671 | $1,174,123 | $1,242,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,697 | 18,339 | 25,042 | 25,499 | 17,280 |
| Accrued Expenses | 20,950 | 19,432 | 15,455 | 15,654 | 15,860 |
| TOTAL | $51,896 | $41,871 | $44,452 | $44,967 | $36,816 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,352 | 11,744 | 12,149 | 12,078 | 12,409 |
| TOTAL | $53,720 | $55,242 | $56,734 | $57,691 | $59,026 |
| Total Liabilities | $105,616 | $97,113 | $101,186 | $102,658 | $95,842 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,164 | 57,647 | 50,337 | 50,249 | 50,107 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -1,385,570 | -1,288,132 | -1,203,204 | -1,102,997 | -1,014,686 |
| Other shareholders' equity | 1,552 | 2,651 | 125 | 1,303 | 1,442 |
| TOTAL | $1,169,927 | $1,242,637 | $988,485 | $1,071,465 | $1,146,206 |
| Total Liabilities And Equity | $1,275,543 | $1,339,750 | $1,089,671 | $1,174,123 | $1,242,048 |